arrow
L

Luke Howard

imperial college nhs trust
H指数:69
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The added value of echocardiography in pulmonary arterial hypertension risk assessment an artificial intelligence machine learning–derived analysis of the ULTRA RIGHT VALUE registry

超声心动图在肺动脉高压风险评估中的附加价值:一项基于人工智能机器学习的ULTRA RIGHT VALUE注册研究分析

2026-09-170
OAAI
Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registry

肺动脉内膜剥脱术前后的药物治疗长期效果——来自英国CURATE登记研究的见解

2026-03-210
PRE
The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension

肺动脉高压全球患者调查:了解儿童肺动脉高压的隐形负担

2026-03-020
PRE
The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients

肺动脉高压全球患者调查:了解患者的经历和观点

2025-12-225
PRE
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment

肺动脉高压中男性的生存劣势:与病因、年龄、疾病严重程度、合并症和治疗无关

2025-12-160
OAAI
Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension

评估帕萨生帕戈口服制剂在肺动脉高压中的疗效:来自GRIPHON及其开放标签扩展研究的完整观察期关于生存、安全性和给药方案模式的见解

2025-11-140
PRE
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study

Seralutinib治疗成人肺动脉高压:TORREY开放标签扩展研究

2025-08-110
OA
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension

肥胖合并肺动脉高压患者的特征、预后及欧洲心脏病学会和欧洲呼吸学会风险分层

CHEST
IF8.6
2025-04-160
PRE
Sustained benefit with seralutinib treatment: Lessons from the open-label extension (OLE) of the TORREY study
2024-10-300
PRE
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
2024-07-261
OAAI
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism

慢性血栓栓塞性肺动脉高压和肺栓塞的共享和不同基因组学研究

2024-06-153
OAAI
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension

根据循环利尿剂在肺动脉高压中使用的表型和结局

2024-06-130
OA